-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Fifty years after the original Asilomar Meeting on Recombinant DNA, new stakeholders in biotechnology reconvened at the Spirit of Asilomar and Future of Biotechnology 2025 Conference. The objective was the responsible advancement of biotechnology, with open-en…
pubmed
Chemla Y, Voigt CA
2026
置信度 0.82
-
Peptide therapeutics offer high target selectivity and low toxicity, but their clinical utility remains constrained by rapid proteolysis in vivo and negligible oral bioavailability. Incorporating non-canonical amino acids (ncAAs) provides a robust molecular en…
pubmed
Deng C, Fan Z, Xu Y, Cao M 等
2026
置信度 0.82
-
Peptidoglycan is an essential component of the bacterial cell wall, providing mechanical strength and maintaining cell shape. It consists of glycan chains crosslinked by short peptide stems, resulting in a chemically heterogeneous macromolecule that remains ch…
pubmed
Emmanuel BG, DelMistro G, Anderson AC, Vandenende C 等
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
The global probiotic market is expanding rapidly, driven by growing demand for accessible strategies to support gut health, preventive care, and microbiome-based interventions. However, this commercial growth contrasts with the limited number of clinically val…
pubmed
Chen J, Chou CP, Liu Y
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
MicroRNAs (miRNAs) are small non-coding RNA molecules essential for growth and development in eukaryotes. In plants, the master gene DICER-LIKE 1 (DCL1) catalyzes the biogenesis of miRNAs by processing double-stranded precursors that give rise to mature miRNAs…
pubmed
Aguilar-Cruz A, Flores-Sandoval E, Xu Y, Yu Y 等
2026
置信度 0.82
-
Both gem-dichlorocyclobutenones and cyclopropanols are versatile building blocks in organic synthesis. Herein, we report a Cu/dppp-catalyzed SN2'-type allylic substitution of gem-dichlorocyclobutenones with cyclopropanols. The reaction proceeds smoothly via a …
pubmed
Liu MM, An XD, Wang JF, Tian P 等
2026
置信度 0.82
-
Living systems operate far from equilibrium, continuously consuming energy to maintain transient functional compartments. Mimicking such dynamic organization through bottom-up self-assembly remains a central challenge in systems chemistry and synthetic biology…
pubmed
Srivastava A, Maity A, Kumar P, Rana S
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
The transition toward a sustainable bioeconomy necessitates the development of robust microbial platforms capable of C1 chemical valorization, particularly the conversion of methanol into high-value chemicals. Komagataella phaffii is a premier methylotrophic h…
pubmed
Choi Y, Kim A, Kang NK
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
This review highlights key advances in chemical biology reported in 2025, curated by students in the Advanced Chemical Biology course (Ch/Bi145) at the California Institute of Technology (Caltech). The selected studies span advances in bioconjugation and bioor…
pubmed
Ashton-Rickardt GP, Chung DK, Corman SA, Gilbert MS 等
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
Bioorthogonal chemistry provides a versatile strategy for programming nanomedicines beyond static carrier design. It enables post-synthetic installation of functional modules on nanoparticle surfaces, spatiotemporal control of payload activation and release, a…
pubmed
Im S, Koo S, Kim JS
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Correction to: npj Systems Biology and Applications https://doi.org/10.1038/s41540-025-00621-y , published online 02 December 2025
europepmc
2026
置信度 0.80
-
Nutrient limitation is a characteristic feature of poorly perfused tumors. In contrast to well-perfused tissues, nutrient deficits in tumors impose metabolic constraints on cancer cells. The metabolic constraints created by the tumor microenvironment can lead …
pubmed
Jonker PB, Sadullozoda M, Cognet G, Apiz Saab JJ 等
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Virtual cell is an emerging technology that integrates multiple disciplines, including biology, computer science, and artificial intelligence, to simulate cellular structures and functions. Compared with traditional methods, virtual cell technology offers a mo…
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Africa is entering a new era of cancer research, driven by renewed commitments to genomic innovation, data equity, and strengthened cancer registry systems. The "Harnessing Functional Genomics in Cancer Research: Opportunities for Diagnosis and Treatment" conf…
pubmed
Rix CL, Buberwa EB, Amofa J, Maurihungirire U 等
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Mosquito repellents are personal protection tools against mosquito-borne diseases, but their effectiveness varies across active ingredients, formulations, and mosquito species. This systematic review followed PRISMA 2020 guidance to summarize human studies pub…
pubmed
Faridah L, Nurhakim RA, Astuti RRUNW, Melanie 等
2026
置信度 0.82
-
europepmc
2025
置信度 0.80
-
europepmc
2025
置信度 0.80
-
Exosomes, extracellular vesicles of 30-150 nm generated via fusion of multivesicular bodies with the plasma membrane, have evolved from poorly characterized cellular byproducts into a promising platform for translational medicine. Their intrinsic biological pr…
pubmed
Shkurnikov M, Tonevitsky A
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2025
置信度 0.80
-
europepmc
2025
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2025
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2025
置信度 0.80
-
europepmc
2025
置信度 0.80
-
europepmc
2025
置信度 0.80
-
europepmc
2025
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
crossref
2025-12-14T14:55:19Z
置信度 0.70
-
Abstract A typical cell therapy product comprises engineered cells that detect disease-related molecular cues in their surrounding or on a surface of a target cell, and activate a response that alleviates disease symptoms or eradicates diseased cells. mRNA as …
crossref
Matteo Lampis, Yaakov Benenson
2025-04-28T03:00:16Z
置信度 0.70
-
crossref
2025-08-15T07:12:14Z
置信度 0.70